IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $716,000 | +6.2% | 15,140 | +35.8% | 0.07% | +84.6% |
Q4 2019 | $674,000 | -0.1% | 11,150 | -1.1% | 0.04% | +21.9% |
Q3 2019 | $675,000 | -28.9% | 11,270 | -23.7% | 0.03% | -23.8% |
Q2 2019 | $950,000 | +24.2% | 14,780 | +56.7% | 0.04% | +40.0% |
Q1 2019 | $765,000 | -44.4% | 9,430 | -71.4% | 0.03% | -28.6% |
Q2 2018 | $1,376,000 | -19.7% | 33,010 | -15.0% | 0.04% | -23.6% |
Q1 2018 | $1,713,000 | -12.3% | 38,855 | 0.0% | 0.06% | -8.3% |
Q4 2017 | $1,954,000 | -0.8% | 38,855 | 0.0% | 0.06% | -3.2% |
Q3 2017 | $1,970,000 | +39.4% | 38,855 | +39.9% | 0.06% | +63.2% |
Q2 2017 | $1,413,000 | – | 27,770 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |